Chagin Karen Deborah 4
4 · Context Therapeutics Inc. · Filed Jun 9, 2025
Insider Transaction Report
Form 4
Chagin Karen Deborah
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-06-09+153,000→ 153,000 totalExercise: $0.70Exp: 2035-06-08→ Common Stock (153,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on June 9, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.